CB-002

N/A

Report date: 2022/08/24 20:00:31

Base Information

Drug NameCB-002
Drug Alias NameGlucosylceramide enriched liposomal mitoxantrone (Ceronco Biosciences)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA intercalatorsTopoisomerase (DNA) II alpha inhibitors
TargetsTopoisomerase (DNA) II alphaDNA
Therapy Area/IndicationsPancreatic NeoplasmsPrecursor Cell Lymphoblastic Leukemia-Lymphoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCeronco Biosciences Bv
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCeronco Biosciences Bv
Active IndicationsN/A
Inactive IndicationsPancreatic NeoplasmsPrecursor Cell Lymphoblastic Leukemia-Lymphoma

Other Information

ATC CodeN/A
Related LinksN/A